Mineralys Therapeutics, Inc. · NASDAQ:MLYS
FMR LLC reported a 6.30% stake in Mineralys Therapeutics, Inc. (Schedule 13G)
Event Dec 31, 2025 · Filed Feb 5, 2026
FMR LLC reported a 6.30% stake in Mineralys Therapeutics, Inc., 5,017,509 shares, as a passive investor on Dec 31, 2025. Filed Feb 5, 2026 (Schedule 13G).
- Stake
- 6.30%
- Shares
- 5,017,509
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| FMR LLC | 6.30% | 5,017,509 |
| Abigail P. Johnson | 6.30% | 5,017,509 |
Source
Related
- Mineralys Therapeutics, Inc.
- FMR LLC
- Mineralys Therapeutics, Inc. shareholders
- Schedule 13G/A · FMR LLC · Aug 6, 2026
- Form 4 · Peterson Kristine · Oct 20, 2026
- Form 4 · Coats Lonnel · Oct 20, 2026
- Form 4 · Congleton Jon · Oct 2, 2026
- Form 4 · Slingsby Brian Taylor · Sep 24, 2026
- Form 4 · Warren Eric · Sep 22, 2026